These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20476927)

  • 1. C-reactive protein at the interface between innate immunity and inflammation.
    Peisajovich A; Marnell L; Mold C; Du Clos TW
    Expert Rev Clin Immunol; 2008 May; 4(3):379-90. PubMed ID: 20476927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein: ligands, receptors and role in inflammation.
    Marnell L; Mold C; Du Clos TW
    Clin Immunol; 2005 Nov; 117(2):104-11. PubMed ID: 16214080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and the acute phase response.
    Gewurz H; Mold C; Siegel J; Fiedel B
    Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [C-reactive protein and atherosclerosis].
    Xie LQ; Wang X
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):113-8. PubMed ID: 15285415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is C-reactive protein a marker of inflammation?].
    Dupuy AM; Terrier N; Sénécal L; Morena M; Leray H; Canaud B; Cristol JP
    Nephrologie; 2003; 24(7):337-41. PubMed ID: 14650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
    Abou-Raya A; Abou-Raya S
    Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein in atherosclerosis: A causal factor?
    Paffen E; DeMaat MP
    Cardiovasc Res; 2006 Jul; 71(1):30-9. PubMed ID: 16624260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Reactive protein and its implications in systemic lupus erythematosus.
    de Carvalho JF; Hanaoka B; Szyper-Kravitz M; Shoenfeld Y
    Acta Reumatol Port; 2007; 32(4):317-22. PubMed ID: 18159197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune response in rainbow trout (Oncorhynchus mykiss) against primary and secondary infections with Yersinia ruckeri O1.
    Raida MK; Buchmann K
    Dev Comp Immunol; 2009; 33(1):35-45. PubMed ID: 18760303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C; Wetterö J
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?].
    Yosef-Levi IM; Grad E; Danenberg HD
    Harefuah; 2007 Dec; 146(12):970-4, 996. PubMed ID: 18254451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
    Rhew EY; Ramsey-Goldman R
    Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation.
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM
    Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases.
    Vermeire S; Van Assche G; Rutgeerts P
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):580-6. PubMed ID: 16327837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
    Suh CH; Chun HY; Ye YM; Park HS
    Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
    Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.